138 related articles for article (PubMed ID: 29493465)
1. Riluzole Inhibits Proliferation, Migration and Cell Cycle Progression and Induces Apoptosis in Tumor Cells of Various Origins.
Lemieszek MK; Stepulak A; Sawa-Wejksza K; Czerwonka A; Ikonomidou C; Rzeski W
Anticancer Agents Med Chem; 2018; 18(4):565-572. PubMed ID: 29493465
[TBL] [Abstract][Full Text] [Related]
2. Glutamate release inhibitor, Riluzole, inhibited proliferation of human hepatocellular carcinoma cells by elevated ROS production.
Seol HS; Lee SE; Song JS; Lee HY; Park S; Kim I; Singh SR; Chang S; Jang SJ
Cancer Lett; 2016 Nov; 382(2):157-165. PubMed ID: 27612558
[TBL] [Abstract][Full Text] [Related]
3. Riluzole mediates anti-tumor properties in breast cancer cells independent of metabotropic glutamate receptor-1.
Speyer CL; Nassar MA; Hachem AH; Bukhsh MA; Jafry WS; Khansa RM; Gorski DH
Breast Cancer Res Treat; 2016 Jun; 157(2):217-228. PubMed ID: 27146584
[TBL] [Abstract][Full Text] [Related]
4. Riluzole synergizes with paclitaxel to inhibit cell growth and induce apoptosis in triple-negative breast cancer.
Speyer CL; Bukhsh MA; Jafry WS; Sexton RE; Bandyopadhyay S; Gorski DH
Breast Cancer Res Treat; 2017 Nov; 166(2):407-419. PubMed ID: 28780701
[TBL] [Abstract][Full Text] [Related]
5. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells.
Li JP; Yang YX; Liu QL; Pan ST; He ZX; Zhang X; Yang T; Chen XW; Wang D; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1627-52. PubMed ID: 25834401
[TBL] [Abstract][Full Text] [Related]
6. Riluzole exerts distinct antitumor effects from a metabotropic glutamate receptor 1-specific inhibitor on breast cancer cells.
Dolfi SC; Medina DJ; Kareddula A; Paratala B; Rose A; Dhami J; Chen S; Ganesan S; Mackay G; Vazquez A; Hirshfield KM
Oncotarget; 2017 Jul; 8(27):44639-44653. PubMed ID: 28591718
[TBL] [Abstract][Full Text] [Related]
7. Anti-cancer effect of metabotropic glutamate receptor 1 inhibition in human glioma U87 cells: involvement of PI3K/Akt/mTOR pathway.
Zhang C; Yuan XR; Li HY; Zhao ZJ; Liao YW; Wang XY; Su J; Sang SS; Liu Q
Cell Physiol Biochem; 2015; 35(2):419-32. PubMed ID: 25613036
[TBL] [Abstract][Full Text] [Related]
8. Metabotropic glutamate receptor-1: a potential therapeutic target for the treatment of breast cancer.
Speyer CL; Smith JS; Banda M; DeVries JA; Mekani T; Gorski DH
Breast Cancer Res Treat; 2012 Apr; 132(2):565-73. PubMed ID: 21681448
[TBL] [Abstract][Full Text] [Related]
9. Riluzole: A neuroprotective drug with potential as a novel anti‑cancer agent (Review).
Blyufer A; Lhamo S; Tam C; Tariq I; Thavornwatanayong T; Mahajan SS
Int J Oncol; 2021 Nov; 59(5):. PubMed ID: 34713302
[TBL] [Abstract][Full Text] [Related]
10. Novel thienopyrimidine analogues as potential metabotropic glutamate receptors inhibitors and anticancer activity: Synthesis, In-vitro, In-silico, and SAR approaches.
Khedr MA; Abu-Zied KM; Zaghary WA; Aly AS; Shouman DN; Haffez H
Bioorg Chem; 2021 Apr; 109():104729. PubMed ID: 33676314
[TBL] [Abstract][Full Text] [Related]
11. Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pathway.
Niu NK; Wang ZL; Pan ST; Ding HQ; Au GH; He ZX; Zhou ZW; Xiao G; Yang YX; Zhang X; Yang T; Chen XW; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1555-84. PubMed ID: 25792811
[TBL] [Abstract][Full Text] [Related]
12. Danusertib, a potent pan-Aurora kinase and ABL kinase inhibitor, induces cell cycle arrest and programmed cell death and inhibits epithelial to mesenchymal transition involving the PI3K/Akt/mTOR-mediated signaling pathway in human gastric cancer AGS and NCI-N78 cells.
Yuan CX; Zhou ZW; Yang YX; He ZX; Zhang X; Wang D; Yang T; Pan SY; Chen XW; Zhou SF
Drug Des Devel Ther; 2015; 9():1293-318. PubMed ID: 25767376
[TBL] [Abstract][Full Text] [Related]
13. Antiproliferative and Apoptotic Effect of Dendrosomal Curcumin Nanoformulation in P53 Mutant and Wide-Type Cancer Cell Lines.
Montazeri M; Pilehvar-Soltanahmadi Y; Mohaghegh M; Panahi A; Khodi S; Zarghami N; Sadeghizadeh M
Anticancer Agents Med Chem; 2017; 17(5):662-673. PubMed ID: 27604683
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, anticancer activity and effects on cell cycle profile and apoptosis of novel thieno[2,3-d]pyrimidine and thieno[3,2-e] triazolo[4,3-c]pyrimidine derivatives.
Kandeel MM; Refaat HM; Kassab AE; Shahin IG; Abdelghany TM
Eur J Med Chem; 2015 Jan; 90():620-32. PubMed ID: 25499930
[TBL] [Abstract][Full Text] [Related]
15. Induction of apoptosis by genipin inhibits cell proliferation in AGS human gastric cancer cells via Egr1/p21 signaling pathway.
Ko H; Kim JM; Kim SJ; Shim SH; Ha CH; Chang HI
Bioorg Med Chem Lett; 2015 Oct; 25(19):4191-6. PubMed ID: 26283511
[TBL] [Abstract][Full Text] [Related]
16. Plumbagin induces G2/M arrest, apoptosis, and autophagy via p38 MAPK- and PI3K/Akt/mTOR-mediated pathways in human tongue squamous cell carcinoma cells.
Pan ST; Qin Y; Zhou ZW; He ZX; Zhang X; Yang T; Yang YX; Wang D; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1601-26. PubMed ID: 25834400
[TBL] [Abstract][Full Text] [Related]
17. Induction of HT-29 Colon Cancer Cells Apoptosis by Pyrogallol with Growth Inhibiting Efficacy Against Drug-Resistant
Revathi S; Hakkim FL; Kumar NR; Bakshi HA; Rashan L; Al-Buloshi M; Hasson SSAA; Krishnan M; Javid F; Nagarajan K
Anticancer Agents Med Chem; 2018; 18(13):1875-1884. PubMed ID: 30081791
[TBL] [Abstract][Full Text] [Related]
18. Eupatilin, a dietary flavonoid, induces G2/M cell cycle arrest in human endometrial cancer cells.
Cho JH; Lee JG; Yang YI; Kim JH; Ahn JH; Baek NI; Lee KT; Choi JH
Food Chem Toxicol; 2011 Aug; 49(8):1737-44. PubMed ID: 21554918
[TBL] [Abstract][Full Text] [Related]
19. 3,3',4', 5'-Tetramethoxychalcone inhibits human oral cancer cell proliferation and migration via p53-mediated mitochondrial-dependent apoptosis.
Lai CK; Rao YK; Chang KR; Lin CW; Su HL; Chang CS; Lai CH; Tzeng YM
Anticancer Res; 2014 Apr; 34(4):1811-9. PubMed ID: 24692714
[TBL] [Abstract][Full Text] [Related]
20. Osteosarcoma cell proliferation and survival requires mGluR5 receptor activity and is blocked by Riluzole.
Liao S; Ruiz Y; Gulzar H; Yelskaya Z; Ait Taouit L; Houssou M; Jaikaran T; Schvarts Y; Kozlitina K; Basu-Roy U; Mansukhani A; Mahajan SS
PLoS One; 2017; 12(2):e0171256. PubMed ID: 28231291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
